This represents an average monthly savings of $39,100 over the two years or $469,200 per year. When we examined the cost savings associated with each of the three measures mentioned above, we found that most of the savings were due to the restricted drugs and therapeutic interchange policies. The intravenous to oral switchover was not as successful as we had hoped. When we examined the results with two drugs in particular, metronidazole and cotrimoxazole, the cost reduction per year attributable to these dn1gs was only $1,489 and $2,546 respectively.
In an attempt to remedy this situation, we decided to see what the effect of specific interventions would be on the percentage of patients switched from intravenous lo oral therapy. We felt that there were essentially three steps at which interventions could be made and these are desc1;bed below.
As part of our antimicrobial formulary policy, a number of drugs have been identified which can be given intravenously as well as orally. These include the following: metronidazole, clindamycin, cotrimoxazole, fluconazole, cefuroxime, erythromycin, acyclovir, cloxacillin, ciprofloxacin and cephalexin. Whenever one of these drugs is ordered to be given intravenously, the pharmacy sends up a yellow sticker to remind the physician that the drug may also be given orally. For each of these drugs , the corresponding sticker, or 'sequential therapy reminder' lists pertinent information regarding the price, dose and frequency of administration. The sticker is placed on the patient's chart by the ward nurse, and hopefully the patient's physician will respond lo this gentle reminder. We were disappointed to find that in only 27% of eligible cases was the intravenous to oral switch actually being made.
The three points at which interventions could lake place are:
Step 1 -the pharmacy when the slickers are sent up with the intravenous drug
Step 2 -the ward where the stickers are placed on the patient's chart
Step 3 -the physician.
A summer student working at our hospital was assigned this task. Each intervention was carried out for two weeks and the results averaged to provide data for a one week period. When the student intervened at step 1. she herself sent the yellow stickers to the ward; this increased compliance from 27% to 40%. For step 2, she put the stickers onto the chart herself and compliance increased 1.o 52%. When physicians did nol respond lo lhe yellow slicker. she discussed the program with lhe individual physician and this increased 1.he response rate lo 76%. This translated into a saving of $1.000 per week. We feel that 1.he important point lo be realized is that good programs are not sufficient. Despite lhe best inlenlions of all involved, careful follow-up is critical lo the success of any antimicrobial policy.
